# Interplay among BRCA1, SIRT1, and Survivin during BRCA1-Associated Tumorigenesis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/interplay-among-brca1-sirt1-and-survivin-during-brca1-associated-tumorigenesis/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Rui-Hong Wang,Zheng Yin,Hyun‐Seok Kim,Xiaoling Xu,Liu Cao,Tyler Lahusen,Mi‐Hye Lee,Cuiying Xiao,Athanassios Vassilopoulos,Weiping Chen,Kevin Gardner,Yan-Gao Man,Mien‐Chie Hung,Toren Finkel,Chu‐Xia Deng |
| Citations | 359 |
| DOI | 10.1016/j.molcel.2008.09.011 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.cell.com/article/S1097276508006564/pdf |
| OpenAlex ID | https://openalex.org/W2034591470 |
| PMID | 18851829 |
| Type | article |
| Year | 2008 |

## Paper authors

- [Zheng Yin](https://scholariq.org/researchers/zheng-yin/)

## Paper primary topic

- [CRISPR and Genetic Engineering](https://scholariq.org/topics/crispr-and-genetic-engineering/)

## Paper topics

- [CRISPR and Genetic Engineering](https://scholariq.org/topics/crispr-and-genetic-engineering/)
- [Sirtuins and Resveratrol in Medicine](https://scholariq.org/topics/sirtuins-and-resveratrol-in-medicine/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.